Dcf Advisers, LLC Idera Pharmaceuticals, Inc. Transaction History

Dcf Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 12, 2021	SELL	$1.23 - $5.98 $23,068 - $112,154	-18,755 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$2.09 - $5.18 $180,252 - $446,749	-86,245 Reduced 82.14%	18,755 $69,000
Q3 2020 Nov 13, 2020	SELL	$1.71 - $2.68 $3,729 - $5,845	-2,181 Reduced 2.03%	105,000 $225,000
Q1 2020 May 12, 2020	BUY	$1.06 - $2.15 $59,497 - $120,679	56,130 Added 109.95%	107,181 $141,000
Q4 2019 Feb 12, 2020	BUY	$1.45 - $2.79 $74,023 - $142,432	51,051 New	51,051 $93,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Dcf Advisers, LLC with notifications on news.